A 'Gold-Standard' Study Debunks Trump's Paracetamol Claims
A recent study, considered the gold standard in evidence-based research, has conclusively refuted President Trump's baseless claims linking paracetamol (known in the US as Tylenol) to autism in children. The study, published in The Lancet, analyzed 43 studies and found no evidence that taking paracetamol during pregnancy increases the risk of autism, ADHD, or intellectual disability in children.
Dr. Joseph Sgroi, a gynaecologist and senior lecturer at the University of Melbourne, emphasized the safety of paracetamol when used as directed. He stated, 'When rigorous methods are applied, accounting for all biases, the previously suggested harms do not hold up.' Dr. Sgroi also highlighted the well-established risks of untreated pain and high maternal temperatures during pregnancy, which can lead to miscarriage, preterm birth, and congenital anomalies.
In contrast, Trump and Kennedy, lacking medical training, have urged mothers to endure pain without medication. Trump stated, 'Taking Tylenol is not good,' and recommended limiting its use during pregnancy unless medically necessary. However, The Lancet's review exposed the flawed foundations of these claims, noting that many studies linking paracetamol to autism were prone to biases.
The Therapeutic Goods Administration (TGA) guidelines for paracetamol use recommend adults and children over 12 take 500 to 1000 mg every four to six hours as needed, with a maximum adult dose of 4000 mg in 24 hours. For younger children, the dose is 15 mg per kg, administered every four to six hours, with no more than four doses in 24 hours. Paracetamol should always be used according to the label directions, and individuals should not take more than one paracetamol-containing medication at a time.
For the latest news and updates, download the 9News app on Apple App Store or Google Play. Remember, this information is general in nature, and for personalized health advice, always consult your GP or healthcare professional.
